KETERLAMBATAN DIAGNOSIS KANKER OVARIUM DAN DAMPAKNYA TERHADAP PROGNOSIS PASIEN DI NEGARA BERKEMBANG

Dewi; Ernawati

doi:10.62354/jurnalmedicare.v4i3.212

Authors

Dewi Universitas Muhammadiyah Gresik
Ernawati Universitas Muhammadiyah Gresik

DOI:

https://doi.org/10.62354/jurnalmedicare.v4i3.212

Keywords:

ovarian cancer, survical, patient prognosis, developing countries

Abstract

This study is a systematic review of 10 international journals published between 2020 and 2025, examining the diagnosis, treatment, and survival of ovarian cancer patients, particularly in low- and middle-income countries (LMICs). The findings indicate that delayed diagnosis and treatment are the primary causes of poor survival rates. Other contributing factors include limited access to healthcare services, variations in histological subtypes, and socioeconomic and geographical disparities. In Indonesia, the average survival time for ovarian cancer patients is only five months, significantly lower than the global average. In Sub-Saharan Africa, the five-year survival rate is approximately 45%, with notable variation between countries. The study also identifies that moderate delays in surgery during the early stages do not necessarily worsen outcomes if clinical management is properly conducted. This review recommends several strategic interventions, such as enhancing early detection, strengthening referral systems, increasing public awareness of early symptoms, and improving the capacity of oncology services. Reducing ovarian cancer mortality requires collaboration among governments, healthcare providers, and communities to expand equitable access to quality cancer care in developing countries.

Downloads

Download data is not yet available.

References

Azangou-Khyavy, M., Ghasemi, E., Rezaei, N., Khanali, J., Kolahi, A. A., Malekpour, M. R., Heidari‐Foroozan, M., Nasserinejad, M., Mohammadi, E., Abbasi-Kangevari, M., Ghamari, S. H., Ebrahimi, N., Koolaji, S., Khosravifar, M., Fateh, S. M., Larijani, B., & Farzadfar, F. (2024). Global, regional, and national quality of care index of cervical and ovarian cancer: a systematic analysis for the global burden of disease study 1990–2019. BMC Women’s Health, 24(1), 1–12. https://doi.org/10.1186/s12905-024-02884-9

Gizaw, M., Parkin, D. M., Stöter, O., Bukirwa, P., Seife, E., Chesumbai, G., Korir, A., Liu, B., Manraj, S. S., Nda, G., Somdyala, N. I. M., & Kantelhardt, E. J. (2024). Ovarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry study. International Journal of Cancer, 154(11), 1911–1919. https://doi.org/10.1002/ijc.34877

Habteyes, A. T., Deressa, J. T., & Kassa, R. T. (2025). The effect of waiting time on ovarian cancer survival in oncology centres, Addis Ababa, Ethiopia: a retrospective cohort study. BMC Women’s Health, 25(1), 36. https://doi.org/10.1186/s12905-025-03566-w

Hong, K., Liu, Y., Yin, H., Huang, K., Pu, X.-L., & Zhu, Z.-X. (2024). Identifying Factors Contributing to Delayed Diagnosis of Ovarian Cancer: A Comprehensive Analysis. International Journal of Women’s Health, Volume 16(September), 1463–1473. https://doi.org/10.2147/ijwh.s473381

Huepenbecker, S. P., Sun, C. C., Fu, S., Zhao, H., Primm, K., Rauh-Hain, J. A., Fleming, N. D., Giordano, S. H., & Meyer, L. A. (2022). Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States. International Journal of Gynecological Cancer, 32(9), 1153–1163. https://doi.org/10.1136/ijgc-2022-003696

Lawson-Michod, K. A., Watt, M. H., Grieshober, L., Green, S. E., Karabegovic, L., Derzon, S., Owens, M., McCarty, R. D., Doherty, J. A., & Barnard, M. E. (2022). Pathways to ovarian cancer diagnosis: a qualitative study. BMC Women’s Health, 22(1), 1–16. https://doi.org/10.1186/s12905-022-02016-1

Meena, R. K., Syed, N. A., Sheikh, Z. A., Guru, F. R., Mir, M. H., Banday, S. Z., MP, A. K., Parveen, S., Dar, N. A., & Bhat, G. M. (2022). Patterns of Treatment and Outcomes in Epithelial Ovarian Cancer: A Retrospective North Indian Single-Institution Experience. JCO Global Oncology, 8, 1–8. https://doi.org/10.1200/go.22.00032

Mulisya, O., Sikakulya, F. K., Mastaki, M., Gertrude, T., & Jeff, M. (2020). The Challenges of Managing Ovarian Cancer in the Developing World. Case Reports in Oncological Medicine, 2020, 1–4. https://doi.org/10.1155/2020/8379628

Mustapha, A., Yahya, A., Ahmadu, O., Bello, N., Ahmed, S., & Oguntayo, A. (2023). EP291/#959 Dying undiagnosed: challenges of management of pelvic masses in a resource-poor setting in Northwestern Nigeria. 64(4), A198–A199. https://doi.org/10.1136/ijgc-2023-igcs.358

Rustamadji, P., Wiyarta, E., Nuryanto, K. H., Anggraeni, T. D., Kusuma, F., Purwoto, G., Winarto, H., Heliyanti, T., Tjahjadi, H., Hayati, A., Sartika, R. A. D., Prasetyo, S., & Andrijono, A. (2025). A Decade of Ovarian Cancer in Indonesia: Epidemiology and Survival Analysis from 2010 to 2020. Journal of Clinical Medicine, 14(5). https://doi.org/10.3390/jcm14051692

Vali, M., Maleki, Z., Nikbakht, H. A., Hassanipour, S., Kouhi, A., Nazemi, S., hajizade-valokolaee, M., Nayeb, M. R., & Ghaem, H. (2023). Survival rate of cervical cancer in Asian countries: a systematic review and meta-analysis. BMC Women’s Health, 23(1), 1–11. https://doi.org/10.1186/s12905-023-02829-8

Zhao, J., Chen, R., Zhang, Y., Wang, Y., & Zhu, H. (2024). Impact of Treatment Delay on the Prognosis of Patients with Ovarian Cancer: A Population-based Study Using the Surveillance, Epidemiology, and End Results Database. Journal of Cancer, 15(2), 473–483. https://doi.org/10.7150/jca.87881

Zouzoulas, D., Tsolakidis, D., Sofianou, I., Karalis, T., Aristotelidis, M., Tzitzis, P., Deligeoroglou, E., Topalidou, M., Timotheadou, E., & Grimbizis, G. (2025). The Impact of Surgery Delay on Early-Stage Ovarian Cancer. Life, 15(1), 1–11. https://doi.org/10.3390/life15010122